Dashboard
Curated content

Companies
Funding rounds
Exits
Investors
Accelerators
Matching tool
Investment heatmap

News

Powered by

EIT Health
European Union
dealroom.co

Contact
FAQ
Privacy

Companies
Apellis Pharmaceuticals
Team
Team

Apellis Pharmaceuticals

Platform of novel therapeutic compounds for the treatment of autoimmune diseases.

Launch date

2008

Employees

501-1000 people

Market cap

€4.2b

Enterprise valuation

€4.3b (Public information from Sep 2024)

Share price

$35.63 APLS

Waltham Massachusetts (HQ)

http://apellis.com

https://twitter.com/apellispharma https://www.linkedin.com/company/apellis https://apps.apple.com/app/id1395446956

View job openings

B2C
manufacturing
health
biotechnology

hard tech
biotechnology
biotech and pharma
verified unicorns and $1b exits
post ipo $1b
autoimmune

Authorizing premium user...